These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670 [TBL] [Abstract][Full Text] [Related]
10. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [TBL] [Abstract][Full Text] [Related]
11. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL) for children and adolescents. Drachenberg KJ; Heinzkill M; Urban E; Woroniecki SR Allergol Immunopathol (Madr); 2003; 31(5):270-7. PubMed ID: 14572416 [TBL] [Abstract][Full Text] [Related]
13. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy. Bonvalet M; Moussu H; Wambre E; Ricarte C; Horiot S; Rimaniol AC; Kwok WW; Horak F; de Beaumont O; Baron-Bodo V; Moingeon P Clin Exp Allergy; 2012 Dec; 42(12):1745-55. PubMed ID: 23181790 [TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of injected allergen immunotherapy for treatment of grass pollen allergy in elderly patients with allergic rhinitis. Bozek A; Cudak A; Walter Canonica G Allergy Asthma Proc; 2020 Jul; 41(4):271-277. PubMed ID: 32605697 [No Abstract] [Full Text] [Related]
16. Effect of AIT in children including potential to prevent the development of asthma. Valovirta E Allergy; 2011 Jul; 66 Suppl 95():53-4. PubMed ID: 21668856 [TBL] [Abstract][Full Text] [Related]
17. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet. Nelson H; Lehmann L; Blaiss MS Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864 [TBL] [Abstract][Full Text] [Related]
18. Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients. Howarth P; Malling HJ; Molimard M; Devillier P Allergy; 2012 Mar; 67(3):321-7. PubMed ID: 22142377 [TBL] [Abstract][Full Text] [Related]
19. Grass pollen immunotherapy: where are we now. Würtzen PA; Gupta S; Brand S; Andersen PS Immunotherapy; 2016; 8(4):399-411. PubMed ID: 26973122 [TBL] [Abstract][Full Text] [Related]
20. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis]. Wolthers OD; Høst A; Frederiksen B; Halken S Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]